Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Nivalis Therapeutics Inc (NVLS)?

Consequently, some big names have jumped into Nivalis Therapeutics Inc (NASDAQ:NVLS) headfirst. OrbiMed Advisors, led by Samuel Isaly, created the most outsized position in Nivalis Therapeutics Inc (NASDAQ:NVLS). OrbiMed Advisors had $0.5 million invested in the company at the end of the quarter. Philip Hempleman’s Ardsley Partners also initiated a $0.1 million position during the quarter.

Let’s now review hedge fund activity in other stocks – not necessarily in the same industry as Nivalis Therapeutics Inc (NASDAQ:NVLS) but similarly valued. These stocks are Xerium Technologies, Inc. (NYSE:XRM), Corium International Inc (NASDAQ:CORI), Delta Apparel, Inc. (NYSEAMEX:DLA), and ArQule, Inc. (NASDAQ:ARQL). This group of stocks’ market values are similar to NVLS’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
XRM 12 17640 1
CORI 3 19184 -1
DLA 2 8336 -1
ARQL 8 35313 1

As you can see these stocks had an average of 6 hedge funds with bullish positions and the average amount invested in these stocks was $20 million. That figure was $63 million in NVLS’s case. Xerium Technologies, Inc. (NYSE:XRM) is the most popular stock in this table. On the other hand Delta Apparel, Inc. (NYSEAMEX:DLA) is the least popular one with only 2 bullish hedge fund positions. Compared to these stocks Nivalis Therapeutics Inc (NASDAQ:NVLS) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
This is a FREE report from Insider Monkey. Credit Card is NOT required.